Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Ivabradine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,432Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic Pharma Gains USFDA Approval for Ivabradine Tablets
    Alembic Pharma Gains USFDA Approval for Ivabradine Tablets

    12 Nov 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/alembic-pharma-gains-usfda-final-approval-for-ivabradine-tablets-5-mg-and-7-5-mg/

    EXPRESSPHARMA
    12 Nov 2024
    Share Share
    When is a Period Not a Period? The Curious Case of Ivabradine & Exclusivity
    When is a Period Not a Period? The Curious Case of Ivabradine & Exclusivity

    01 May 2019

    // Kurt R. Karst FDALAWBLOG

    http://www.fdalawblog.net/2019/04/when-is-a-period-not-a-period-the-curious-case-of-ivabradine-and-pediatric-exclusivity/

    Kurt R. Karst FDALAWBLOG
    01 May 2019
    Share Share
    Accord Healthcare's Ivabradine Receives Approval In Europe
    Accord Healthcare's Ivabradine Receives Approval In Europe

    06 Jun 2017

    // EMA

    https://www.pharmacompass.com/pdf/news/accord-healthcare-ivabradine-receives-approval-in-europe-1496838000.pdf

    EMA
    06 Jun 2017
    Share Share
    Accord's Ivabradine Receives Approval In Europe
    Accord's Ivabradine Receives Approval In Europe

    01 Jun 2017

    // EMA

    https://www.pharmacompass.com/pdf/news/accord-healthcare-ltd-ivabradine-receives-approval-in-europe-1496399137.pdf

    EMA
    01 Jun 2017
    Share Share
    Six new medicines backed for EU approval
    Six new medicines backed for EU approval

    28 Mar 2017

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/six_new_medicines_backed_for_eu_approval_1190077

    Selina McKee PHARMA TIMES
    28 Mar 2017
    Share Share
    Zentiva, k.s. Gets EU Nod For Ivabradine
    Zentiva, k.s. Gets EU Nod For Ivabradine

    08 Feb 2017

    // EMA

    https://www.pharmacompass.com/pdf/news/zentiva-ks-gets-eu-nod-for-ivabradine-1486639700.pdf

    EMA
    08 Feb 2017
    Share Share